Cardiogramme Echographie Salle d'opération Salle d'opération
Logo   Accueil | Table des matières | Téléchargements | Liens |   Mentions légales   | Contact |Abréviations
Logo  

Bibliographie

Lectures conseillées

ARMSTRONG EJ, RUTLEDGE JC, ROGERS JH. Coronary artery revascularization in patients with diabetes mellitus. Circulation 2013; 128:1675-85
ARNST HR, BOSSAERT LL, DANCHIN N, NIKOLAOU NI. European Resuscitation Council Guidelines for resuscitation 2010. Section 5. Initial management of acute coronary syndrome. Resuscitation 2010; 81:1333-63
BICCARD BM. Detection and management of perioperative myocardial ischemia. Curr Opin Anesthesiol 2014; 27:336-43
CREA F, LIUZZO G. Pathogenesis of acute coronary syndrome. J Am Coll Cardiol 2013; 61:1-11
FIHN SD, GARDIN JM, ABRAMS J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/ATA Guideline for the diagnosis and management of patients with stable ischemic heart disease. J Am Coll Cardiol 2012; 60:e44-e164
FLEISHER LA, BECKMAN JA, BROWN KA, et al. ACC/AHA 2007 Guidelines on perioperative cardiovascular evaluation and care for non-cardiac surgery. A report of the ACC/AHA Task Force on practice guidelines (Writing Commnittee to revise the 2002 Guidelines on perioperative cardiovascular evaluation non-cardiac surgery). Circulation 2007; 116:e418-e499
HILLIS LD, SMITH PK, ANDERSON JL, et al. 2011 ACCF/AHA Guideline for coronary artery bypass graft surgery: Executive summary. Anesth Analg 2012; 114:11-45
JNEID H, ANDERSON JL, WRIGHT RS, et al. 2012 ACCF/AHA focused update of the Guideline for the management of patients with unstable angina / non-ST-elevation myocardial infarction (Updating the 2007 Guideline and replacing the 2011 focused update). Circulation 2012; 126:875-910
KORTE W, CATTANEO M, CHASSOT PG, et al. Perioperative management of antiplatelet therapy in patients with coronary artery disease. Thromb Haemost 2011; 105: 743-9
LEVINE GN, BATES ER, BLANKENSHIP JC, et al. 2011 ACCF/AHA/SCAI Guideline for percutaneous coronary intervention: executive summary. Circulation 2011; 124:2574-609
PAGEL PS. Myocardial protection by volatile anesthetics in patients undergoing cardiac surgery: A critical review of the laboratory and clinical evidence. J Cardiothorac Vasc Anesth 2013; 27:972-82
POLDERMANS D, BAX JJ, BOERSMA E, et al. Guidelines for pre-operative risk assessment and perioperative management in non-cardiac surgery. The Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by he European Society of Anaesthesiology (ESA). Eur Heart J 2009; 30:2769-812
SCHONBERGER RB, HADDADIN AS. The anesthesia of patient with acute coronary syndrome. Anesthesiology Clin 2010 ; 28 :55-66
STEG G, JAMES SK, ATAR D, et al. ESC Guidelines for the management of acute myocardial infarction in pratients presenting with ST-segment elevation. Eur Heart J 2012; 33:2569-619
WIJNS W, KOHL P, DANCHIN N, et al. Guidelines on myocardial revascularization. The Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2010; 31:2501-55

 

Références

1 ACKER MA, PARIDES MK, PERRAULT LP, et al. Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med 2014; 370:23-32
2 Agostini P, Biondi-Zoccai GGL, Gasparini GL, et al. Is bare-metal stenting superior to balloon angioplasty for small vessel coronary artery disease ? Evidence from a meta-analysis of randomized trials. Eur Heart J 2005; 26:881-9
3 ALLMAN KC, SHAW LJ, HACHAMOVITCH R, et al. Myocardial viability testing and impact of revascularisation on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002; 39:1151-8
4 ANDERSON JL, ADAMS CD, ANTMAN EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction. Circulation 2007;116:e148-e304
4a ANDERSSON C, MERIE C, JORGENSEN M, et al. Association of -blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery. A Danish nationwide cohort study. JAMA Intern Med 2014; 174:336-44
5 ANTMAN EM, BRAUNWALD E. ST-elevation myocardial infarction: Pathology, pathophysiology, and clinical features. In: ZIPES DP, et al, eds. Braunwald’s heart disease. A textbook of cardiovascular medicine, 7th edition. Philadelphia, Elsevier-Saunders, 2005, 1141-65
6 ANTMAN EM, COHEN M, BERNINK PJ, et al. The TIMI risk score fur unstable angina/non-ST elevation myocardial infarction: a method for prognostication and therapeutic decision making. JAMA 2000; 284:835-42
7 ANTMAN EM, TANASIJEVIC MJ, THOMPSON B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996; 335:1342-7
8 ARBAB-ZADEH A, NAKANO M, VIRMANI R, FOSTER V. Acute coronary events. Circulation 2012; 125:1147-56
9 ARJOMAND H, TURI ZG, McCORMICK D, GOLDBERG S. Percutaneous coronary intervention: Historical, perspectives, current status, and future directions. Am Heart J 2003; 146:787-96
10 ARMSTRONG EJ, RUTLEDGE JC, ROGERS JH. Coronary artery revascularization in patients with diabetes mellitus. Circulation 2013; 128:1675-85
11 ARMSTRONG PW, GERSHLICK AH, GOLDSTEIN P, et al. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. N Engl J Med 2013; 368:1379-87
12 ARNST HR, BOSSAERT LL, DANCHIN N, NIKOLAOU NI. European Resuscitation Council Guidelines for resuscitation 2010. Section 5. Initial management of acute coronary syndrome. Resuscitation 2010; 81:1333-63
13 AUERBACH AD, GOLDMAN L. Assessing and reducing the cardiac risk of noncardiac surgery. Circulation 2006; 113:1361-76
14 BADNER NH, KNILL RL, BROWN JE, et al. Myocardial infarction after noncardiac surgery. Anesthesiology 1998; 88:572-8
15 BANGALORE S, STEG PG, DEEDWANIA P, et al. -blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA 2012; 308:1340-9
16 BANGALORE S, WETTERSLEV J, PRANESH S, et al. Perioperative  blockers in patients having non-cardiac surgery: a meta-analysis. Lancet 2008; 372:1962-76
17 BANKI N, KOPELNIK A, TUNG P, et al. Prospective analysis of prevalence, distribution, and rate of recovery of left ventricular systolic function in patients with subarachnoid hemorrhage. J Neurosurg 2006; 105:15-20
18 BAPAPULLE MN, JOSEPH L, BELISLE P, et al. A hierarchical Bayesian meta-analysis of randomized clinical trials of drug-eluting stents. Lancet 2004; 364:583-91
19 BARI Investigators. The Bypass Angioplasty Revascularization Investigation investigators. Seven-year outcome in the bypass angioplasty revascularization investigation by treatment and diabetes staus. J Am Coll Cardiol 2000; 35:1122-9
20 BARI Investigators. The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol 2007; 49:1600-6
21 BARON JF, BERTRAND M, BARRE E, et al. Combined epidural and general anesthesia versus general anesthesia for abdominal aortic surgery. Anesthesiology 1991; 75:611-8
22 BARON JF, MUNDLER O, BERTRAND M, et al. Dipyridamole-thallium scintigraphy and gated radionuclide angiography to assess cardiac risk before abdominal aortic surgery. N Engl J Med 1994 ; 330:663-9
23 BAUER SM, CAYNE NS, VEITH FJ. New developments in the preoperative evaluation and perioperative management of coronary artery disease in patients undergoing vascular surgery. J Vasc Surg 2010; 51:242-51
24 Bavry AA, Kumbhani DJ, Helton TJ, Bhatt DL. Risk of thrombosis with the use of sirolimus-eluting stents for percutaneous coronary intervention (from registry and clinical trial data). Am J Cardiol 2005; 95:1469-72
25 BEATTIE WS, BADNER NH, CHOI P. Epidural analgesia reduces postoperative myocardial infarction : a meta-analysis. Anesth Analg 2001 ; 93 :853-8
26 BERGER PB, BELLOT V, BELL MR, et al. An immediate invasive strategy for the treatment of acute myocardial infarction early after noncardiac surgery. Am J Cardiol 2001; 87:1100-2
27 BERGER A, ECKERT P, STAUFFER JC, WASSERFALLEN JB. Le syndrome coronarien aigu. Genève: Médecine & Hygiène, 2002
28 BERGER JS, FRYE CB, HARSHAW Q, et al. Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery. J Am Coll Cardiol 2008; 52:1693-701
29 Bergquist BD, Leung JM, Bellows WH - Transesophageal echocardiography in myocardial revascularisation: I Accuracy of intraoperative real-time interpretation. Anesth Analg 1996; 82:1132-8
30 Bergquist BD, Bellows WH, Leung JM. - Transesophageal echocardiography in myocardial revascularisation: II. Influence on intraoperative decision making. Anesth Analg 1996; 82:1139-45
31 BETTEX DA, WARNER P, BOSSHART M, et al. Role of sevoflurane in organ protection during cardiac surgery in children: a randomized controlled trial. Anesth Analg 2014; 000:000
31a BICCARD BM. Detection and management of perioperative myocardial ischemia. Curr Opin Anesthesiol 2014; 27:336-43
32 BICCARD BM, RODSETH R. A meta-analysis of the prospective randomised trials of coronary revascularisation before noncardiac vascular surgery with attention to the type of coronary revascularisation performed. Anaesthesia 2009; 64:1105-13
33 BIGNAMI E, BIONDI-ZOCCAI G, LANDONI G, et al. Volatile anesthetics reduce mortality in cardiac surgery. J Cardiothorac Vasc Anesth 2009; 23:594-9
34 BIGNAMI E, GRECO T, BARILE L, et al. The effect of isoflurane on survival and myocardial infarction: A meta-analysis of randomized controlled studies. J Cardiothorac Vasc Anesth 2013; 27:50-8
35 BLAISE GA, WITZELING TM, STILLVINAY P, et al. Fentanyl is devoid of major effects on coronary vasoreactivity and myocardial metabolism in experimental animals. Anesthesiology 1990; 72:535
36 BLAKE GJ, RIDKER PM. Inflammatory biomarkers and cardiovascular risk prediction. J Intern Med 2002; 252:283-94
37 BLOMBERG SG, SVORKDAL N. Thoracic epidural anesthesia for treatment of refractory angina pectoris. Bail Clin Anesthesiol 1999; 13:83-99
38 BODE RH, LEWIS KP, ZARICH SW, et al. Cardiac outcome after peripheral vascular surgery: comparison of regional and general anesthesia. Anesthesiology 1996; 84:3-13
39 BODEN WE, O’ROURKE RA, TEO KK, et al. Optimal medical therapy with or without PCI for stable coronary artery disease. N Engl J Med 2007; 356:1503-16
40 BOENGLER K, SCHULZ R, HEUSCH G. Loss of cardioprotection with ageing. Cardiovasc Res 2009; 83:247-61
41 BOERSMA E, POLDERMANS D, BAX JJ et al. Predictors of cardiac events after major vascular surgery. Role of clinical characteristics, dobutamine echocardiography and -blocker therapy. JAMA 2001; 285:1865-73
42 BOOTH J, CLAYTON T, PEPPER J, et al. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease. Six-year follow-up from stent or surgery trial (SoS). Circulation 2008; 118:381-8
43 BORISSOFF JI, SPRONK HMH, TEN CATE H. The hemostatic system as a modulator of atherosclerosis. N Engl J Med 2011; 364:1746-60
43a BOTTO F, ALONSO-COELLO P, CHAN MT, et al. Myocardial injury after noncardiac surgery: a large international prospective cohort study establishing diagnostic criteria: characteristics, predictors, and 30-day outcomes. Anesthesiology 2014:120:564-78
44 BRAUNWALD E. Is myocardial stunning important from a clinical standpoint? In: KLONER RA, PRZYKLENK K. ed. Stunned Myocardium. Marcel Dekker, Inc, 1993, p 441-452
45 BRAUNWALD E, ANTMAN E, BEASLEY JW, et al. ACC/AHA Guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. Circulation 2000; 102:1193-209
46 BRAUNWALD E, MORROW DA. Unstable angina. Is it time for a Requiem ? Circulation 2013; 127:2452-7
47 BRAUNWALD E, RUTHERFORD JD. Reversible ischemic left ventricular dysfunction: Evidence for the «hibernating myocardium». J Am Coll Cardiol 1986; 8:1467
48 BRAVATA DM, GIENGER AL, McDONALD KM, et al. Systematic review: The comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery. Ann Intern Med 2007; 147:703-16
49 BREEN P, LEE JW, POMPOSELLI F, PARK KW. Timing of high-risk vascular surgery following coronary artery bypass surgery: A 10-year experience from an academic medical centre. Anaesthesia 2004; 59:422-7
50 BRENER SJ, LYTLE BW, SCHNEIDERJP, et al. Association between CK-MB elevation after percutaneous or surgical revascularisation and three-year mortality. J Am Coll Cardiol 2002; 40:1961-7
51 BRILAKIS ES, BANERJEE S, BERGER PB. Perioperative management of patients with coronary stents. J Am Coll Cardiol 2007; 49:2145-50
52 Brilakis ES, Orford JL, Fasseas P, et al. Outcome of patients undergoing balloon angioplasty in the two months prior to noncardiac surgery. Am J Cardiol 2005, 96: 512-4
53 BRODIE B, POKHAREL Y, FLEISHMAN N, et al. Very late stent thrombosis after primary percutaneous coronary intervention with bare-metal and drug-eluting stents for ST-segment elevation myocardial infarction. JACC Cardiovasc Interv 2011; 4:30-8
54 BUCKLEY O, DI CARLI M. Predicting benefit from revascularisation in patients with ischemic heart failure. Imaging of myocardial ischemia and viability. Circulation 2011; 123:444-50
55 BUFFINGTON CW. Hemodynamic determinants of ischemic myocardial dysfunction in the presence of coronary stenosis in dogs. Anesthesiology 1985; 63:651-62
56 Burger W, Chemnitius JM, Kneissl GD, Rücker G. Low-dose aspirin for secondary cardiovascular prevention – cardiovascular risks after its preoperative withdrawal versus bleeding risks with its continuation – review and meta-analysis. J Int Med 2005; 257:399-414
57 BYRNE RA, KASTRATI A, MASSBERG S, et al. Biodegradable polymer versus permanent polymer drug-eluting stents and everolimus- versus sirolimus-eluting stents in patients with coronary artery disease : 3-year outcome from a randomized clinical trial. J Am Coll Cardiol 2011 ; 58 :1325-31
58 CAMPEAU L. Grading in angina pectoris. Circulation 1976; 54:522
59 CASON BA, GAMPERL AK, SLOCUM RE, HICKEY RF. Anesthetic-induced preconditioning: previous administration of isoflurane decreases myocardial infarct size in rabbits. Anesthesiology 1997; 87: 1182-90
60 CASSAR A, HOLMES DR, RIHAL C, et al. Chronic coronary artery disease: diagnosis and management. Mayo Clin Proc 2009; 84:1130-46
61 CASSCELLS W, NAGHAVI M, WILLERSON JT. Vulnerable atherosclerotic plaque. A multifocal disease. Circulation 2003; 107:2072-5
62 CERQUEIRA MD, WEISSMAN NJ, DILSIZIAN V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: Statement for healthcare professionals from the cardiac imaging committee of the Council on clinical cardiology of the American Heart Association. Circulation 2002; 105:539-42
63 CHAN MY, PRONOVOST PJ. Clinical utility of biomarkers in myocardial injury. Curr Opin Anesthesiol 2004; 17:49-55
64 CHASSOT PG. Données non publiées, CHUV 2008
65 CHASSOT PG, DELABAYS A, SPAHN DR. Preoperative evaluation of patients with, or at risk of, coronary artery disease undergoing non-cardiac surgery. Br J Anaesth 2002; 89:747-59
66 CHASSOT PG, DELABAYS A, SPAHN DR. Perioperative antiplatelet therapy: The case for continuing therapy in patients at risk of myocardial infarction. Brit J Anaesth 2007; 99:316-28
67 CHASSOT PG, MARCUCCI C, DELABAYS A, SPAHN DR. Perioperative antiplatelet drugs. Am Fam Physician 2010; 82:1484-9
68 CHEITLIN MD, ARMSTRONG WF, AURIGEMMA GP, et al. ACC/AHA/ASE 2003 Guideline update for the clinical application of echocardiography: Summary article. Circulation 2003; 108:1146-62
69 CHENG D, VEGAS A. Anesthesia for the surgical management of ischemic heart disease. In: THYS DM, ed. Textbook of cardiothoracic anaesthesiology. New York: McGraw-Hill Co, 2001, 530-88
70 CHRISTOPHERSON R, BEATTIE C, FRANK SM, et al. Perioperative morbidity in patients randomized to epidural or general anesthesia for lower extremity vascular surgery. Anesthesiology 1993; 79:422-34
71 CICALA S, DE SIMONE G, ROMAN MJ, et al. Prevalence and prognostic significance of wall-motion abnormalities in adults without clinically recognized cardiovascular disease. Circulation 2007; 116:143-50
72 COLLET JP, CUISSET T, RANGE G, et al. Bedside monitoring to adjust antiplatelet therapy for coronary stenting. N Engl J Med 2012; 367:2100-9
73 COMMUNALE ME, BODY SC, LEY C, et al. The concordance of intraoperative left ventricular wall-motion abnormalities and electrocardiographic ST segment changes. Aneesthesiology 1998; 88:945-54
74 CONZEN PF, FISCHER S, DETTER C, PETER K. Sevoflurane provides greater protection of the myocardium than propofol in patients undergoing off-pump coronary artery bypass surgery. Anesthesiology 2003; 99:826-33
75 COUTURE P, Denault A, Limoges P, et al. Mechanisms of hemodynamic changes during off-pump coronary artery bypass surgery. Can J Anaesth 2002; 49:835-49
76 CREA F, LIUZZO G. Pathogenesis of acute coronary syndrome. J Am Coll Cardiol 2013; 61:1-11
77 DAEMEN J, BOERSMA E, FLATHER M, et al. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease. Circulation 2008; 118:1146-54
78 D’ANCONA G, BARTOLOZZI F, BOJERS AJJC, et al. Intraoperative graft patency verification in coronary artery surgery: modern diagnostic tools. J Cardiothorac Vasc Anesth 2009; 23:232-8
79 dangas gd, caixeta a, mehran r, et al. Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction. Circulation 2011; 123:1745-56
80 DANIAS PG, ROUSSAKIS A, IONNIDIS JP. Diagnostic performance of coronary magnetic resonance angiography as compared against conventional X-ray angiography: a meta-analysis. J Am Coll Cardiol 2004:44:1867-76
81 D’ASCENZO F, BOLLATI M, CLEMENTI F, et al. Incidence and predictors of coronary stent thrombosis: Evidence from an international collaborative meta-analysis including 30 studies, 221’066 patients, and 4276 thromboses. Int J Cardiol 2013; 167: 575-84
82 DAWOOD MM, GUPTA DK, SOUTHERN J, et al. Pathology of fatal perioperative myocardial infarction: implications regarding physiopathology and prevention. Int J Cardiol 1996; 57:35-44
83 DE BRUYNE B, PIJLS NHJ, KALESAN B, et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 2012; 367:991-1001
84 DE HERT SG. Cardioprotection with volatile anesthetics: clinical relevance. Curr Opin Anesthesiol 2004; 17:57-62
85 DE HERT SG, CROMHEECKE S, TEN BROECKE PW, et al. Effects of propofol, desflurane and sevoflurane on recovery of myocardial function after coronory surgery in elderly high-risk patients. Anesthesiology 2003; 99:314-23
86 DE HERT SG, TURANI F, MATHUR S, STOWE DF. Cardioprotection with volatile anesthetics: mechanisms and clinical implications. Anesth Analg 2005; 100:1584-95
87 DE HERT S, VAN DER LINDEN PJ, CROMHEECKE S, et al. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology 2004; 101:299-310
88 DE HERT S, VLASSELAERS D, BARBE R, et al. A comparison of volatile and non volatile agents for cardioprotection during on-pump coronary surgery. Anaesthesia 2009; 64:953-60
89 DE LUCA G, DIRKSEN MT, SPAULDING C, et al. Drug-eluting stents vs bare-metal stents in primary angioplasty. A pooled patient-level meta-analysis of randomized trials. Arch Intern Med 2012; 172:611-21
90 DE LUCA G, SURYAPRANATA H, OTTERVANGER JP, et al. Time-delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute counts. Circulation 2004; 109:1233-8
91 DESAY ND, COHEN EA, NAYLOR CD et al. A randomized comparison of radial artery and saphenous vein coronary bypass grafts. N Engl J Med 2004; 351:2302-9
92 DE SOUZA G, LEWIS MC, TERRIET MF. Severe bradycardia after remifentanil. Anesthesiology 1997; 84:1019-25
92a DEVEREAUX PJ, CHAN MT, ALONSO-COELO P, et al. Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA 2012; 307:2295-304
93 DEVEREAUX PJ, YANG H, YUSUF S, et al, for the POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing nopn-cardiac surgery (POISE-trial): a randomised controlled trial. Lancet 2008; 371:1839-47
94 DOMANSKI MJ, MAHAFFEY K, HASSELBLAD V, et al. Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery. JAMA 2011; 305:585-91
95 DUNNING J, VERSTEEGH M, FABBRI A, et al. Guidelines on antiplatelet and anticoagulation management in cardiac surgery. Eur J Cardiothorac Surg 2008; 34:73-92
96 DURST R, BOGOT N, GILON D, DRENGER B. Potential role for coronary computerized angiography for assessing preoperative ischemic risk. J Cardiothorac Vasc Anesth 2010; 24:348-55
97 DUTTA P, COURTIES G, WEI Y, et al. Myocardial infarction accelerates atherosclerosis. Nature 2012; 487:325-9
98 EBERLI D, CHASSOT PG, SULSER T, et al. Urologic surgery and anti-platelet drugs after cardiac and cerebrovascular accidents. J Urology 2010; 183:2128-36
99 EBERT TJ, KANITZ DD, KAMPINE JP. Inhibition of synpathetic neural outflow during thiopental anesthesia in humans. Anesth Analg 1990; 71:319-26
100 EBERT T.J., MUZZI M. - Sympathetic hyperactivity during desflurane anesthesia in healthy volunteers: A comparison with isoflurane. Anesthesiology 1993; 79: 444-453
101 Eisenberg MJ, Richard PR, Libersan D, Filion KB. Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents. Circulation 2009; 119:1634-42
102 Eisenstein EL, Anstrom KJ, Kong DF, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 2007; 297:159-68
103 EL AZAAB SR, ROSSEEL PM, DE LANGE JJ, et al. Effect of sevoflurane on the ex vivo secretion of TNF-alpha during and after coronary artery bypass surgery. Eur J Anaesthesiol 2003; 20:380-4
104 ELLIS SG, HERTZER NR, YOUNG JR, et al. Angiographic correlates of cardiac death and myocardial infarction complicating major non-thoracic vascular surgery. Am J Cardiol 1996; 77:1126-28
105 ELSASSER A, SCHLEPPER M, KLOVEKORN VP, et al. Hibernating myocardium: An incomplete adaptation to ischemia. Circulation 1997; 96:2920-31
106 ELTZSCHIG HK, Rosenberger p, löffler m, et al. Impact of intraoperative transesophageal echocardiography on surgical decisions in 12,566 patients undergoing cardiac surgery. Ann Thorac Surg 2008; 85:845-53
107 FARKOUH ME, DOMANSKI M, SLEEPER LA, et al (FREEDOM trial investigators). Strategies for multivessel revascularization in patients with diabetes. N Engl J Med 2012; 367:2375-84
108 FAROOQ V, VAN KLAVEREN D, STEYERBERG EW, et al. Anatomical and clinical characteristics to guide decision-making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet 2013; 381:639-50
109 FAWCETT WJ, EDWARDS RE, QUINN AC, et al. Thoracic epidural analgesia started after cardiopulmonary bypass: adrenergic, cardiovascular and respiratory sequelae. Anaesthesia 1997; 52:294-9
110 FELLAHI JL, GUEX X, RICHOMME X, et al. Short-and long-term prognostic value of ppostoperative cardiac troponin I concentration in patients undergoing coronary artery bypass grafting. Anesthesiology 2003; 99:270-4
111 Ferreiro JL, Sibbing D, Angiolillo DJ. Platelet function testing and risk of bleeding. Thromb Haemost 2010; 103:1128-35
112 FIHN SD, GARDIN JM, ABRAMS J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/ATA Guideline for the diagnosis and management of patients with stable ischemic heart disease. J Am Coll Cardiol 2012; 60:e44-e164
113 FISCHER GW, ANYANWU AC, ADAMS DH. Intraoperative classification of mitral valve dysfunction: The role of the anesthesiologist in mitral valve reconstruction. J Cardiothorac Vasc Anesth 2009; 23:531-43
114 FITZGIBBON GM, KAFKA HP, LEACH AJ, eet al. Coronary bypass fate and patient outcome: Angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol 1996; 28:616-26
115 FLEISHER LA, BECKMAN JA, BROWN KA, et al. ACC/AHA 2007 Guidelines on perioperative cardiovascular evaluation and care for non-cardiac surgery. A report of the ACC/AHA Task Force on practice guidelines (Writing Commnittee to revise the 2002 Guidelines on perioperative cardiovascular evaluation non-cardiac surgery). Circulation 2007; 116:e418-e499
116 FLEISCHMANN KE, BECKMAN JA, BULLER CE, et al. ACCF/AHA focused update on perioperative beta blockade. J Am Coll Cardiol 2009; 54:2102-28
117 FLIER S, BUHRE WF, VAN KLEI WA. Cardioprotective effects of perioperative -blockade in vascular surgery patients: fact or fiction ? Curr Opin Anaesthesiol 2011; 24:104-10
118 FLU WJ, VAN KUIJK JP, CHONCHOL M, et al. Timing of preoperative beta-blocker treatment in vascular patients. J Am Coll Cardiol 2010; 56:1922-9
119 FOËX P, BICCARD B. Stunning, hibernation, preconditioning, postconditioning, and the effects of anesthetic drugs. In: Howell S, et al, eds. Heart disease and the surgical patient. New York: Informa Healthcare 2007, 63-86
120 FOËX P, SEAR JW. -blockers and cardiac protection: 5 yr from POISE. Br J Anaesth 2014; 112:206-10
121 FORLANI S, TOMAI F, De PAULIS R, et al. Preoperative shift from glibenclamide to insulin is cardioprotective in diabetic patients undergoing coronary artery bypass surgery. J Cardiovasc Surg 2004; 45:117-2
122 FOX KA, DABBOUS OH, GOLDBERG RJ, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ 2006; 333:1091
123 FOX K, GARCIA MA, ARDISSIMO D, et al. Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Guidelines on the management of stable angina pectoris: executive summary. Eur Heart J 2006; 27:1341-81
124 FRAKER TD, FIHN SD, GIBBONS RJ, et al. ACC/AHA Task Force on Practice Guidelines. Guidelines for the management of patients with chronic stable angina. Circulation 2007; 116:2762-72
125 FRÄSSDORF J, DE HERT S, SCHLACK W. Anaesthesia and myocardial ischaemia/reperfusion injury. Br J Anaesth 2009; 103:89-98
126 FRYE RL, AUGUST P, BROOKS MM, et al, for the BARI-2D Study Group. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 2009; 360; 2503-15
127 FUSTER V, FAYAD ZA, BADIMON JJ. Acute coronary syndromes: biology. Lancet 1999; 353(suppl III):5-9
128 Gaglia MA, Manoukian SV, Waksman R. Novel antiplatelet therapy. Am Heart J 2010; 160:595-604
129 GAGLIA MA, WAKSMAN R. Systematic review of thienopyridine discontinuation and its impact upon clinical outcomes. Eur Heart J 2011; 32:2358-64
130 GARCIA C, JULIER K, BESTMANN L, et al. Preconditioning with sevoflurane decreases PECAM-1 expression and improves one-year cardiovascular outcomes in coronary artery bypass graft surgery. Br J Anaesth 2005; 94:159-65
131 GAUSS A, RÖHM HJ, SCHÄUFFELEN A, et al. Electrocardiographic exercise stress testing for cardiac risk assessment in patients undergoing noncardiac surgery. Anesthesiology 2001 ; 94:38-46
132 GIBSON CM, CANNON CP, DALEY WL, et al. TIMI frame count: A quantitative method assessing coronary artery flow. Circulation 1996; 93:879-95
133 GIBSON CM, MURPHY SA, MARBLE SJ, et al. Relationship of creatine kinase-myocardial band release to thrombolysis in myocardial infarction perfusion grade after intracoronary setnt placement: an ESPRIT substudy. Am Heart J 2002; 143:106-10
134 GIROUD D, LI JM, URBAN P, et al. Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography. Am J Cardiol 1992; 69:729-32
135 GODET G, RIOU B, BERTRAND M, et al. Does preoperative coronary angioplasty improve perioperative cardiac outcome ? Anesthesiology 2005; 102:739-46
136 GOERTZ AW, SEELIG W, HEINRICH H, et al. Influence of high thoracic epidural anesthesia on left ventricular contractility assessed using the end-systolic pressure-length relationship. Acta Anaesthesiol Scand 1993; 37:38-44
137 GOLDSTEIN JA, GALLAGHER MJ, O’NEILL WW, et al. A randomized controlled trial of multi-slice coronary computed tomography for evaluation of acute chest pain. J Am Coll Cardiol 2007; 49:863-71
138 GORMAN JH III, RYAN LP, GORMAN RC. Pathophysiology of ischemic mitral insufficiency: Does repair make a difference ? Heart Fail Rev 2006; 11:219-29
139 Grewe PH, Deneke T, Machraoui A, et al. Acute and chronic tissue response to coronary stent implantation: Pathologic findings in human specimen. J Am Coll Cardiol 2000; 35:157-63
140 GRIGIONI F, ENRIQUEZ-SARANO M, ZEHR KJ, et al. Ischemic mitral regurgitation: Long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 2001; 103:1759-64
141 Grines CL, Bonow RO, Casey DE, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents. A Science Advisory from the American Heart Association, American College of Cardiology, Society of Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation 2007; 49:734-9
142 GUARRACINO F, LANDONI G, TRITAPEPE L, et al. Myocardial damage prevented by volatile anaesthetics: A multicenter randomized controlled study. J Cardiothorac Vasc Anesth 2006; 20:477-83
143 GUYTON RA. Coronary artery bypass is superior to drug-eluting stents in multivessel coronary artery disease. Ann Thorac Surg 2006; 81:1949-57
144 GWON HC, HAHN JY, PARK KW, et al. Six-month versus 12-month dual antiplatelet therapy after implantation of drug-elunting stents (EXCELLENT study). Circulation 2012 ; 125 :505-13
145 HAAS F, JENNEN L, HEINZMANN U, et al. Ischemically compromised myocardium displays different time-courses of functional recovery: correlation with morphological alterations ? Eur J Cardiothorac Surg 2001; 20:290-8
146 HAHN JY, SONG YB, KIM EK, et al. Ischemic postconditioning during primary percutaneous coronary ontervention. The effects of postconditioning on myocardial reperfusion in patients with ST-segment elevation myocardial infarction (POST) randomized trial. Circulation 2013; 128:1889-96
147 HALBERSMA WB, ARRIGONI SC, MECOZZI G, et al. Four-year outcome of OPCAB no-touch with total arterial Y-graft: making the best treatment a daily practice. Ann Thorac Surg 2009; 88:796-801
147a HAMM CW, BASSAND JP, AGEWALL S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2011; 32:2999-3054
148 HANNAN EL, RACZ MJ, WALFORD G, et al. Long-term outcomes of coronary artery bypass grafting versus stent implantation. N Engl J Med 2005; 352:2174-83
149 HANNAN EL, WU C, WALFORD G, et al. Drug-eluting stents vs. coronary-artery bypass grafting in multivessels coronary disease. N Engl J Med 2008; 358:331-41
150 HASSAN SA, HLATCKY MA, BOOTHROYD DB, et al. Outcomes of noncardiac surgery after coronary bypass surgery or coronary angioplasty in the Bypass Angioplasty Revascularisation Investigation (BARI). Am J Med 2001; 110:260-6
151 HATTORI K, OZAKI Y, ISMAIL TF, et al. Impact of statin therapy on plaque characteristics as assessed by serial OCT, grayscale and integrated backscatter-IVUS. JACC Cardiovasc Imaging 2012; 5:169-77
152 HEIN S, et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart. Circulation 2003; 107:984-91
153 HENEIN MY, GIBSON DG. Long axis function in disease. Heart 1999; 81:229-31
154 HELMAN JD, LEUNG JM, HUDSON RJ, et al. The risk of myocardial ischemia in patients receiving desflurane versus sufentanil anesthesia for coronary artery bypass graft surgery. Anesthesiology 1992; 77:47-62
155 HILLIS LD, SMITH PK, ANDERSON JL, et al. 2011 ACCF/AHA Guideline for coronary artery bypass graft surgery: Executive summary. Anesth Analg 2012; 114:11-45
156 HLADKY MA, BOOTHROYD DB, BRAVATA DM, et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet 2009; 373:1190-7
157 HOHNER P, MEHTA V, SAADA M, et al. Sensitivity and specificity of mechanical and electrocardiographic myocardial ischaemia (MI) monitoring techniques. Br J Anaesth 1993; 70:A26
158 HOHNER P, NANCARROW C, BACKMAN C, et al. Anesthesia for abdominal vascular surgery in patients with coronary artery disease. Part I: Isoflurane produces dose-dependent coronary vasodilatation. Acta Anaesthesiol Scand 1994; 38:780-92
159 Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293 :2126-30
159a IGLESIAS JF. Recommandations pour la prise en charge du Syndrome Coronarien Aigu. CHUV 2012
159b IGLESIAS JF, TAPPONNIER M, HULLIN R, et al. Cellules souches en cardiologie: mythe ou réalité ? Forum Méd Suisse 2013; 13:358-62
160 JACOB M, SMEDIRA N, BLACKSTONE E, et al. Effect of timing of chronic preoperative aspirin discontinuation on morbidity and mortality in coronary artery bypass surgery. Circulation 2011; 123:577-83
161 JAKOBSEN CJ, BERG H, HINDSHOLM KB, et al. The influence of propofol versus sevoflurane anesthesia on outcome in 10’535 cardiac surgical procedures. J Cardiothorac Vasc Anesth 2007; 21:664-71
162 JAFFE R, STRAUSS BH. Late and very late thrombosis of drug eluting stents. Evolving concepts and perspectives. J Am Coll Cardiol 2007; 50:119-27
163 JAIN U, LAFLAMME CJA, AGGARWAL A, et al. Electrocardiographic and hemodynamic changes and their association with myocardial infarction during coronary artery bypass surgery. Anesthesiology 1997; 86:576-91
164 JBS 2 – Joint British Societies’ Guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005; 91(suppl 5):v1-v52
165 JNEID H, ANDERSON JL, WRIGHT RS, et al. 2012 ACCF/AHA focused update of the Guideline for the management of patients with unstable angina / non-ST-elevation myocardial infarction (Updating the 2007 Guideline and replacing the 2011 focused update). Circulation 2012; 126:875-910
166 JONER M, FINN AV, FARB A, et al. Pathology of drug-eluting stents in humans. J Am Coll Cardiol 2006 ; 48 :193-202
167 JONES RH, VELASQUEZ EJ, MICHLER RE, et al. Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med 2009; 360:1705-17
168 JULIER K, DA SILVA R, GARCIA C, et al. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery. Anesthesiology 2003; 98:1315-27
169 KANEKO T, SAITO Y, HIKAWA Y, et al. Dose-dependent prophylactic effect of nicorandil, an ATP-sensitive potassium channel opener, on intra-operative myocardial ischaemia in patients undergoing major abdominal surgery. Br J Anaesth 2001; 86:332-7
170 KASTRATI A, MEHILI J, PACHE J, et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007; 356:1030-9
171 KATRITSIS DG, IOANNIDIS JP. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis. Circulation 2005; 111:2906-12
172 KEHL F, Krolikowski JG, Mraovic B, et al. Hyperglycemia prevents isoflurane-induced preconditioning against myocardial infarction. Anesthesiology 2002; 96:183-8
173 KEMP M, DONOVAN J, HIGHAM H, HOOPER J. Biochemical markers in myocardial injury. Br J Anaesth 2004; 93:63-73
174 KERN MJ. Coronary blood flow and myocardial ischemia. In: ZIPES DP, et al. Braunwald’s Heart disease. A textbook of cardiovascular medicine. 7th edition Philadelphia: Elsevier Saunders, 2005, 1103-28
175 KERN MJ, SAMADY H. Current concepts of integrated coronary physiology in the catheterization laboratory. J Am Coll Cardiol 2010; 55:173-85
176 KERTAI MD, BOERSMA E, BAX JJ, et al. A meta-analysis comparing the prognostic accuracy of six diagnostic tests for predicting perioperative cardiac risk in patients undergoing major vascular surgery. Heart 2003; 89:1327-34
177 KETTLER D, SONNTAG H, DONATH U. Haemodynamics, myocardial mechanics, oxygen requirements, and oxygenation of the human heart during induction of anaesthesia with etomidate. Anaesthesist 1974; 23:116-121-8
178 KIM BK, HONG MK, SHIN DH, et al. A new strategy for discontinuation of dual antiplatelet therapy. J Am Coll Cardiol 2012; 60:1340-8
179 KIM LJ, MARTINEZ EA, FARADAY N, et al. Cardiac ptroponin I predicts short-term mortality in vascular surgery patients. Circulation 2002; 106:2366-71
180 KING SB, KOSINSKI AS, GUYTON RA, et al. Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST). J Am Coll Cardiol 2000; 35:1116-21
181 KING SB, MARSHALL JJ, TUMMALA PE. Revascularization for coronary artery disease: stents versus bypass surgery. Annu Rev Med 2010; 61:199-213
182 KINOSHITA K, TSURUHARA Y, TOKUNAGA K. Delayed time to peak serum myoglobin level as an indicator of cardiac dysfunction following open heart surgery. Chest 1991; 99:1398-403
183 KLOCKGETHER-RADKE AP, FRERICHS A, KETTLER D, HELLIGE G. Propofol and thiopental attenuate the contractile response to vasoconstrictors in human and porcine coronary artery segments. Eur J Anaesthesiol 2000; 17:485-90
184 kock m, blomberg s, emanuelsson h, et al. Thoracic epidural anethesia improves global and regional left ventricular function during stress-induced myocardial ischemia in patients with coronary artery disease. Anesth Analg 1990; 71:625-30
185 KORTE W, CATTANEO M, CHASSOT PG, et al. Perioperative management of antiplatelet therapy in patients with coronary artery disease. Thromb Haemost 2011; 105: 743-9
186 Kotani J, Awata M, Nanto S, et al. Incomplete neointimal coverage of Sirolimus-eluting stents. J Am Coll Cardiol 2006; 47:2108-11
187 KOTTENBERG E, THIELMANN M, BERGMANN L, et al. Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol – a clinical trial. Acta Anaesthesiol Scand 2012; 56:30-8
188 KURISU S, SATO H, KAWAGOE T, et al. Tako-tsubo-like left ventricular dysfunction with ST-segment elevation: A novel cardiac syndrome mimicking acute myocardial infarction. Am Heart J 2002; 143:448-55
189 LAGERQVIST B, DIDERHOLM E, LINDAHL B, et al. FRISC score for selection of patients for an early invasive treatment strategy in unstable coronary artery disease. Heart 2005; 91:1047-52
190 LAMY A, DEVEREAUX PJ, PRABHAKARAN D, et al. Off-pump or on-pump coronary artery bypass grafting at 30 days. N Engl J Med 2012; 366:1489-97
191 LANDESBERG G. The pathophysiology of perioperative myocardial infarction: Facts and perspectives. J Cardiothorac Vasc Anesth 2003; 17:90-100
192 LANDESBERG G. Monitoring for myocardial ischemia. Best Pract Res Clin Anaesthesiol 2005; 19:77-95
193 LANDESBERG G, LURIA MH, COTEV S. et al. Importance of long-duration postoperative ST-segment depression in cardiac morbidity after vascular surgery. Lancet 1993; 341:715-9
194 LANDESBERG G, MOSSERI M, ZAHGER D, et al. Myocardial infarction following vascular surgery: The role of prolonged, stress induced, ST-depression type ischemia. J Am Coll Cardiol 2001; 37:1839-45
195 LANDESBERG G, SHATZ V, AKOPNIK I, et al. Association of cardiac troponin, CK-MB, and postoperative myocardial ischemia with long-term survival after major vascular surgery. J Am Coll Cardiol 2003; 42:1547-54
196 LANDONI G, BIONDI-ZOCCAI GGL, ZANGRILLO A, et al. Desflurane and sevoflurane in cardiac surgery: A meta-analysis of randomized clinical rials. J Cardiothorac Vasc Anesth 2007; 21:502-11
197 LANGE M, REDEL A, SMUL TM, et al. Desflurane-induced preconditioning has a threshold that is lowered by repetitive application and is mediated by beta2-adrenergic receptors. J Cardiothorac Vasc Anesth 2009; 23:607-13
198 LAPPAS GD, STAFFORD-SMITH M. Diagnosis of perioperative ischemia and infarction. In: HOWELL S, et al, Eds. Heart disease and the surgical patient. New York:Informa Healthcare, 2007, 161-96
199 LEACCHE M, ZHAO DX, UMAKANTHAN R, BYRNE JG. Do hybrid procedures have proven clinical utility and are they the wave of the future? Circulation 2012; 125:2504-10
200 Lee th, marcantonio er, mangione cm, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100:1043-9
201 LEMANACH Y, PERREL A, CORIAT P, ET AL. Early and delayed myocardial infarction after abdominal aortic surgery. Anesthesiology 2005; 102:885-91
202 LEONG JY, BAKER RA, SHAH PJ, et al. Clopidogrel and bleeding after coronary artery bypass surgery. Ann Thorac Surg 2005; 80: 928-33
203 LEUNG JM, O’KELLY B, BROWNER WS, et al. Prognostic importance of postbypass regional wall motion abnormalities in patients undergoing CABG surgery. Anesthesiology 1989; 71:16-23
204 LEUNG JM, O’KELLY BF, MANGANO DT. Relationship of regional wall motion abnormalities to hemodynamic indices of myocardial supply and demand in patients undergoing CABG surgery. Anesthesiology 1990; 73:802-9
205 LEVINE GN, BATES ER, BLANKENSHIP JC, et al. 2011 ACCF/AHA/SCAI Guideline for percutaneous coronary intervention: executive summary. Circulation 2011; 124:2574-609
206 LIAKOPOULOS OJ, CHOI YH, HALDENWANG P, et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30’000 patients. Eur Heart J 2008; 29:1548-59
207 LIBBY P. Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med 2013; 368:2004-13
208 LIBBY P, THEROUX P. Pathophysiology of coronary artery disease. Circulation 2005; 111:3481-8
209 LIEBERMAN RW, ORKIN FK, JOBES DR, et al. Hemodynamic predictors of myocardial ischemia during halothane anesthesia for coronary artery revascularisation. Anesthesiology 1983; 59:36-41
210 Likosky DS, DACEY LJ, BARIBEAU YR, et al. Long-term survival of the very elderly undergoing coronary artery bypass grafting.. Ann Thorac Surg 2008; 85:1233-8
211 LONDON MJ, HOLLENBERG M, WONG MG, et al. Intraoperative myocardial ischemia: localization by continuous 12-lead electrocardiography. Anesthesiology 1988; 69:232-41
212 LOSORDO DW, VALE PR, HENDEL RC, et al. Phase1 / 2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation 2002; 100:468-74
213 LUDWIG LM, PATEL HH, GROSS GJ, et al. Morphine enhances pharmacological preconditioning by isoflurane. Anesthesiology 2003; 98:705-11
214 MAEDER MT, ENGEL RP, RICKLI H. Traitement médicamenteux de l’angine de poitrine stable. Forum Med Suisse 2010; 10:746-52
215 MAGNE J, SENECHAL M, DUMESNIL JG, PIBAROT P. Ischemic mitral regurgitation: A complex multifaceted disease. Cardiology 2009; 112:244-59
216 MAGOVERN JA, SAKERT T, MAGOVERN GJ, et al. A model that predicts morbidity and mortality after coronary artery bypass grafting. J Am Coll Cardiol 1996; 28:1147-53
217 Mangano DT. Aspirin and mortality from coronary bypass surgery. N Engl J Med 2002; 347:1309-17
218 MANGANO DT, BROWNER WS, HOLLENBERG M, et al. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The study of Perioperative Ischemia Research Group. N Engl J Med 1990; 323:1781-8
219 MANGANO DT, HOLLENBERG M, FEGERT G, et al. Perioperative myocardial ischemia in patients undergoing non-cardiac surgery. J Am Coll Cardiol 1991; 17:843-57
220 MANNEHIMER C, ELIASSON T, AUGUSTINSSON LE, et al. Electrical stimulation versus coronary artery bypass surgery in severe angina pectoris. The ESBY study. Circulation 1998; 97:1157-63
221 MARON DJ, SPERTUS JA, MANCINI J, et al. Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Agressive druG Evaluation (COURAGE) trial. Am J Cardiol 2009; 104:1055-62
222 MARROQUIN OC, SELZER F, MULUKUTLA SR, et al. A comparison of bare-metal and drug-eluting stents for off-label indications. N Engl J Med 2008; 358:342-52
223 MARTY J, NITENBERG A, BLANCET F. Effects of midazolam on the coronary circulation in patients with coronary artery disease. Anesthesiology 1986; 64:206-12
223a MASHOUR GA, SHARIFPOUR M, FREUNDLICH RE, et al. Perioperative metoprolol and risk of stroke after noncardiac surgery. Anesthesiology 2013; 119:1340-6
224 MASLOW A, GERVINO E, LOWENSTEIN E. Stress Testing. In: THYS DM, HILLEL Z, SCHWARTZ AJ. Textbook of cardiothoracic anesthesiology. New York:McGraw-Hill Co, 2001, 203-232
225 MAURI L, HSIEH W, MASSARO JM, et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007; 356:1020-9
226 MAURIELLO A, SANGIORGI C, FRATONI S, et al. Diffuse and active inflammation occurs in both vulnerable and stable plaques of the entire coronary tree: a hisopathological study of patients dying of acute myocardial infarction. J Am Coll Cardiol 2005; 45:1585-93
227 MAYER N, LEGAT K, WEINSTABL C, et al. Effects of propofol on the function of normal, collateral-dependant, and ischemic myocardium. Anesth Analg 1993; 76:33-9
228 McFALLS EO, WARD HB, MORITZ TE, et al. Coronary artery revascularization before elective major vascular surgery. N Engl J Med 2004; 351:2795-804
229 McLEOD GA, DAVIES HTO, MUNNOCH N, et al. Postoperative pain relief using thoracic epidural analgesia: outstanding success and disappointing failures. Anaesthesia 2001; 56:75-81
230 MEHRAN R, BABER U, STEG PG, et al. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary interventions. PARIS: 2 years results from a prospective observational study. Lancet 2013; 382:1879-88
231 Mehta sr, granger cb, boden we, et al. Early versus delayed invasive intervention in acute coronary syndrome. N Engl J Med 2009; 360:2165-75
232 MERGNER GW, STOLTE AL, FRAME WB, LIM HJ. Combined epidural analgesia and general anesthesia induce ischemia distal to a severe coronary artery stenosis in swine. Anesth Analg 1994; 78:37-45
233 MERIN RG, BERNARD JM, DOURSOUT MF, et al. Comparison of the effects of isoflurane and desflurane on cardiovascular dynamics and regional blood flow in the chronically instrumented dog. Anesthesiology 1991; 74:568-74
234 MESSAS E, GUERRERO JL, HANDSCHUMACHER MD, et al. Paradoxic decrease in ischemic mitral regurgitation with papillary muscle dysfunction. Circulation 2001; 104:1952-7
235 MILLER DR, WELLWOOD M, TEASDALE SJ, et al. Effects of anaesthetic induction on myocardial function and metabolism: A comparison of fentanyl, sufentanil, and alfentanil. Can J Anaesth 1988; 35:219-25
236 MIZUNO K, MIYAMOOTGO A, SATOMURA K, et al. Angioscopic coronary macromorphology in patients with acute coronary disorders. Lancet 1991; 337:809-12
237 MOBILIA G, ZUIN G, ZANCO P, et al. Effect of spinal cord stimulation on regional myocardial blood flow in patients with refractory angina: A positron emission tomography study. G Ital Cardiol 1998; 29:1113-9
238 MOFFITT EA, SCOVIL JE, BARKER RA, et al. The effects of nitrous oxide on myocardial metabolism and hemodynamics during fentanyl or enflurane anesthesia in patients with coronary disease. Anesth Analg 1984; 63:1071-5
239 MOHR FW, MORICE MC, KAPPETEIN AP, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three vessel disease and left main coronary disease. 5-year follow-up of the randomized, clinical SYNTAX trial. Lancet 2013; 381:629-38
240 MOISES VA, MESQUITA CB, CAMPOS O, et al. Importance of intraoperative transesophageal echocardiography during coronary artery surgery without cardiopulmonary bypass. J Am Soc Echocardiogr 1998; 11:1139-44
241 MOLLER JE, PELLIKA PA, HILLIS GS, et al. Prognostic importance of diastolic function and filling pressure in patients with acute myocardial infarction. Circulation 2006; 114:438-44
242 MÖLLHOFF T, THEILMEIER G, VAN AKAN H. Regional anesthesia in patients at coronary risk for noncardiac and cardiac surgery. Curr Opin Anesthesiol 2001; 14:17-25
242a MONTALESCOT G, BOLOGNESE L, DUDEK D, et al. Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndrome. N Engl J Med 2013; 369:999-1010
243 MONTALESCOT G, CAYLA G, COLLET JP, et al. Immediate versus delayed interventions for acute coronary syndromes: A randomized controlled trial. JAMA 2009; 302:947-54
243a MONTALESCOT G, SECHTEM U, ACHENBACH S, et al. 2013 ESC Guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013; 34:2949-3003
244 MORRISON DA, SEHTI G, SACKS J, et al. For the Investigators of the Department of Veterans Affairs Cooperative Study  385, the Angina With Extremely Serious Operative Mortality Evaluation (AWSOME). J Am Coll Cardiol 2001; 38:143-9
245 MORROW DA, ANTMAN EM, CHARLESWORTH A, et al. TIMI risk score for ST-elevation MI: a convenient, beside, clinical score for risk assessment at presentation, Circulation 2000; 102:2031-7
246 MOSES JW, STONE GW, NIKOLSKY E, Mintz GS, et al. Drug-eluting stents in the treatment of intermediate lesions. Pooled analysis from four randomized trials. J Am Coll Cardiol 2006; 47: 2164-71
247 Mullenheim J, Fradorf J, Preckel B, Volker T, Schlack W. Ketamine, but not S(+)-ketamine, blocks ischemic preconditioning in rabbitt hearts in vivo. Anesthesiology 2001; 94:630-6
248 MURRY CE, JENNINGS RB, REIMER KA. Preconditionning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74:1124-36
249 MUZI M, BERENS RA, KAMPINE JP, et al. Venodilatation contributes to propofol-mediated hypotension in humans. Anesth Analg 1992; 74:877-83
250 MUZI M, LOPATKA CW, EBERT TJ. Desflurane-mediated neurocirculatory activation in humans. Effects of concentration and rate of change on responses. Anesthesiology 1996; 79:1035-42
251 NABEL EG, BRAUNWALD E. A tale of coronary artery disease and myocardial infarction. N Engl J Med 2102; 366:54-63
252 NAGHAVI M, LIBBY P, FALK E, et al. From vulnerable plaque to vulnerable patient. A call for new definitions and risk assessment strategies. Part I. Circulation 2003; 108:1664-72
253 NAKAMURA K, HATANO Y, HIRAKATA H, et al. Direct vasoconstrictor and vasodilator effects of propofol in isolated dog arteries. Brit J Anaesth 1992; 68:193-7
254 NASHEF SAM, ROQUES F, MICHEL P, et al. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999; 16:9-13
255 NALYSNYK L, FAHRBACH K, REYNOLDS MW, ZHAO SZ, ROSS S. Adverse events in coronary artery bypass graft (CABG) trials: a systematic review and analysis. Heart 2003; 89:767-72
256 NEUMANN FJ, KASTRATI A, POGATSA-MURRAY G, et al. Evaluation of prolonged antithrombotic pretreatment („cooling-off“ strategy) before interventiuon in patients with unstable coronary syndromes: a randomized controlled trial. JAMA 2003; 290:1593-9
257 NICCOLI G, BURZOTTA F, GALIUTO L. Myocardial no-reflow in humans. J Am Coll Cardiol 2009; 54:281-92
258 NORRIS EJ, BEATTIE C, PERLER BA, et al. Double-masked randomized trial comparing alternate combinations of intraoperative anesthesia and postoperative analgesia in abdominal aortic surgery. Anesthesiology 2001; 95:1054-67
259 NUCIFORA G, BADANO LP, SARRAF-ZADEGAN N, et al. Comparison of early dobutamine stress echocardiography and exercise electrocardiographic testing for management of patients presenting to the emergency department with chest pain. Am J Cardiol 2007; 100:1068-73
260 NUTTALL GA, Brown MJ, Stombaugh JW, et al. Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention. Anesthesiology 2008; 109:588-95
261 O’CONNOR RE, BRADY W, BROOKS SC, et al. 2010 AHA Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Part 10: acute coronary syndromes. Circulation 2010; 122(suppl 3):S787-S817
262 O’GARA PT, KUSHNER FG, ASCHEIM DD, et al. 2013 ACCF/AHA Guideline for the management of ST-elevation myocardial infarction. Circulaion 2013; 127: e362-e425
263 OH JK, GIBBONS RJ, CHRISTIAN TF, et al. Correlation of regional wall motion abnormalities detected by two-dimensional echocardiography with perfusion defect determined by technetium 99m sestamibi imaging in patients treated with reperfusion therapy during acute myocardial infarction. Am Heart J 1996; 131:32-7
264 O’HARA DA, DUFF A, BERLIN JA, et al. The effect of anesthetic technique on postoperative outcomes in hip fracture repair. Anesthesiology 2000; 92:947-57
265 O’KEEFE JH, BARNHART CS, BATEMAN TM. Comparison of stress echocardiography and stress myocardial perfusion scintigraphy for diagnosing coronary artery disease and assessing its severity. Am J Cardiol 1995; 75:25D
266 OLIVER MF, GOLDMAN L, JULIAN DG, et al. Effect of mivazerol on perioperative cardiac complications during non-cardiac surgery in patients with coronary heart disease. Anesthesiology 1999; 91:95-161
267 OPIE LH, HEUSCH G. Pathophysiology. In: OPIE LH. Heart physiology. From cell to circulation. 4th edition. Philadelphia, Lippincott, Williams & Wilkins 2004, p 525-98
268 PAGEL PS. Myocardial protection by volatile anesthetics in patients undergoing cardiac surgery: A critical review of the laboratory and clinical evidence. J Cardiothorac Vasc Anesth 2013; 27:972-82
269 PALMERINI T, BIONDI-ZOCCAI G, DELLA RIVA D, et al. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network analysis. Lancet 2012; 379.1393-402
270 PANTET O, MONNEY P, AEBISCHER N. Le point sur l’ergométrie en 2012 dans le diagnostic de la maladie coronarienne. Forum Med Suisse 2012; 12:578-84
271 PARK KW, LEE J, BREEN P, et al. The risk of perioperative cardiac complications is high in major vascular surgery performed within a month of coronary artery bypass graft surgery. Anesth Analg 2002; 94:S63
272 PARK WY, THOMPSON JS, LEE KK. Effect of epidural anesthesia and analgesia on perioperative outcome: A randomized, controlled Veteran Affairs cooperative study. Ann Surg 2001; 234:560-9
273 PATEL MR, DEHMER GJ, HIRSHFELD JW, et al. ACCF/SCAI/STS/AATS/AHA/ASNC 2009 appropriateness criteria for coronary revascularization, J Am Coll Cardiol 2009; 53:530-53
274 PERRONE-FILARDI P, MUSELLA F, SAVARESE G, et al. Coronary computed tomography: current role and future perspectives for cardiovascular risk stratification. Eur Heart J Cardiovasc Imaging 2012; 13:453-8
275 PICARD MH, DAVIDOFF R, SLEEPER LA, et al, SHOCK Registry Investigators. Echocardiographic predictors of survival and response to early revascularization in cardiogenic shock. Circulation 2003; 107:279-84
276 PIRIOU V, MANTZ J, GOLDFARB G, et al. Sevoflurane preconditioning at 1 MAC only provides limited protection in patients undergoing coronary artery bypass surgery: a randomised bi-centre trial. Br J Anaesth 2007; 99:624-31
277 POLDERMANS D, BAX JJ, BOERSMA E, et al. Guidelines for pre-operative risk assessment and perioperative management in non-cardiac surgery. The Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by he European Society of Anaesthesiology (ESA). Eur Heart J 2009; 30:2769-812
278 POLDERMANS D, BAX JJ, SCHOUTEN O, et al. Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control ? J Am Coll Cardiol 2006; 48:964-9
279 POLDERMANS D, BOERSMA E, BAX JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med 1999; 341:1789-94
280 POLDERMANS D, BOERSMA E BAX JJ, et al. Correlation of location of acute myocardial infarct after non-cardiac vascular surgery with preoperative dobutamine echocardiographic findings. Am J Cardiol 2001; 88:1413-4
281 POLDERMANS D, SCHOUTEN O, VIDAKOVIC R, et al. A clinical randomized trial to evaluate the safety of a non-invasive approach in high-risk patients undergoing major vascular surgery. J Am Coll Cardiol 2007; 49:1763-9
282 PRASAD A, STONE GW, HOLMES DR, GERSH B. Reperfusion injury, microvascular dysfunction, and cardioprotection. Circulation 2009; 120:2105-12
283 PRATT PF, WANG C, WEIHRAUCH D, et al. Cardioprotection by volatile anesthetics: new applications for old drugs ? Curr Opin Anesthesiol 2006; 19:397-403
284 PRICE MJ, ANGIOLILLO DJ, TEIRSTEIN PS, et al. Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention (GRAVITAS trial). Circulation 2011; 124:1132-7
285 RABBITTS JA, JA, Nutall GA, Brown MJ, et al. Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents. Anesthesiology 2008;109: 596-604
286 RÄBER L, KELBAEK H, OSTOIJE M, et al. Effect of Biolimus-eluting stent with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction. JAMA 2012; 308:777-87
287 RAMAKRISHNA H, GHADIMI K, AUGOUSTIDES JGT. Incidental moderate mitral regurgitation in patients undergoing coronary artery bypass grafting: update on guidelines and key randomized trials. J Cardiothorac Vasc Anesth 2014; 28:189-93
288 RAPP HJ, RABETHGE S, LUIZ T, et al. Perioperative ST-segment depression and troponin T release. Identification of patients with highest risk for myocardial damage. Acta Anaesthesiol Scand 1999; 43:124-9
289 REGENBOGEN SE, EHRENFELD JM, LIPSITZ SR, et al. Utility of the surgical Apgar score: Validation in 4119 patients. Arch Surg 2009; 144:30-6
290 REZKALLA SH, KLONER RA. No-reflow phenomenon. Circulation 2002; 105:606-11
291 RIDKER PM, RIFAI N, ROSE L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediciton of first cardiovascular events. N Engl J Med 2002; 347:1557-65
292 RIGG JRA, JAMROZIK K, MYLES PS, et al. Epidural anaesthesia and analgesia and outcome of major surgery: a randomised trial. Lancet 2002; 259:1276-82
293 RIZZELLO V, SCHINKEL AF, BAX JJ, et al. Individual prediction of functional recovery after coronary revascularization in patients with ischemic cardiomyopathy. Am J Cardiol 2003; 91:1406-11
294 ROBERTS WT, BAX JJ, DAVIES LC. Cardiac CT and CT coronary angiography: Technology and application. Heart 2008; 94:781-92
295 ROBINSON BJ, EBERT TJ, O’BRIEN TJ, et al. Mechanisms whereby propofol mediates peripheral vasodilation in humans. Sympathoinhibition or direct vascular relaxation ? Anesthesiology 1997; 86:64-72
296 ROQUES F, NASHEF SAM, MICHEL P, et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 1999; 15 :816-23
297 ROSENFELD BA, BEATTIE C, CHRISTOPHERSON R, et al. The effects of different anesthetic regimens on fibrinolysis and the development of postoperative arterial thrombosis. Anesthesiology 1993; 79:435-43
298 ROUINE-RAPP K, IONESCU P, BALEA M, et al. Detection of intraoperative segmental wall-motion abnormalities by transesophageal echocardiography. Anesth Analg 1996; 83:1141-8
299 SAADA M, CATOIRE P, BONNET F, et al. Effect of thoracic epidural anesthesia combined with general anesthesia on segmental wall motion assessed by transesophageal echocardiography. Anesth Analg 1992; 75:329-35
300 SAADA M, DUVAL AM, BONNET F, et al. Abnormalities in myocardial segmental wall motion during lumbar epidural anesthesia. Anesthesiology 1989; 71:26-32
301 SAVAGE RM, LYTLE BW, ARONSON S, et al. Intraoperative echocardiography is indicated in high-risk coronary artery bypass grafting. Ann Thorac Surg 1997; 64:368-74
302 SAVONITTO S, ARDISSINO D, GRANGER CB, et al. Prognostic value of the admission electrocardiogram in acute coronary syndromes. JAMA 1999; 281:707-11
303 SAVONITTO S, D’URBANO M, CARACCIOLO M, et al. Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of “bridging” antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel. Br J Anaesth 2010; 104:285-91
304 SCHMIDT C, HINDER F, VAN AKEN H, et al. The effect of high thoracic epidural anesthesia on systolic and diastolic left ventricular function in patients with coronary artery diasease. Anesth Analg 2005; 100:1561-9
305 SCHMIDT C, WIRTZ S, VAN AKEN H, et al. Effect of high thoracic epidural anesthesia on global left ventricular function in patients with coronary artery disease. Anesthesiology 2000; 93:A56
306 SCHOMIG A, NDREPEPA G, MEHILLI J, et al. Therapy-dependent influence of time-to-treatment interval on myocardial salvage in patients with acute myocardial infarction treated with coronary artery stenting or thrombolysis. Circulation 2003; 108:1084-9
307 SEAR JW, FOEX P, HOWELL SJ. Effect of chronic intercurrent medication with beta-adrenoreceptor blockade or calcium channel entry blockade on postoperative silent myocardial ischaemia. Br J Anaesth 2000; 84:311-15
308 SEBEL PS, HOKE JF, WESTMORELAND C et al. Histamine concentrations and hemodynamic responses after remifentanil. Anesth Analg 1995; 80:990-6
309 Seki M, Kashimoto S, Nagata O, et al. Are the incidences of cardiac events during noncardiac surgery Japan the same as in the United States and Europe ? Anesth Analg 2005; 100:1236-1240
310 Serruys PW, Kutryk MJB, Ong ATL. Coronary artery stents. N Engl J Med 2006; 354:483-95
311 SERRUYS PW, MORICE MC, KAPPETEIN P, et al. Percutaneous coronary intervention versus coronary artery bypass grafting for severe coronary artery disease. N Engl J Med 2009; 360:961-72
312 SERRUYS PW, UNGER F, DE SOUZA JE, et al. Comparison of coronary artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001; 344:1117-24
313 SHAN R, BICK RJ, POINTDEXTER DJ, et al. Altered adrenergic receptor density in myocardial hibernation in humans: A possible mechanism of depressed myocardial function. Circulation 2000; 102:2599-606
314 SHANNON J, COLOMBO A, ALFIERI O. Do hybrid procedures have proven clinical utility and are they the wave of the future? Circulation 2012; 125:2492-503
315 SHARMA AK, AJANI AE, HAMWI SM, ET AL. Major noncardiac surgery following coronary stenting: When is it safe to operate ? Catheter Cardiovasc Interv 2004; 63:141-5
316 SHOUTEN O, VON DOMBURG RT, BAX JJ, et al. Noncardiac surgery after coronary stenting: Early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events. J Am Coll Cardiol 2007; 49:122-4
317 Shuchman M. Debating the risks of drug-eluting stents. N Engl J Med 2007; 356:325-8
318 SIDDIQI O, FAXON DP. Very late stent thrombosis: current concepts. Curr Opin Cardiol 2012; 27:634-41
319 SIGG DC, COLES JA, GALLAGHER WJ, et al. Opioid preconditioning: Myocardial function and energy metabolism. Ann Thorac Surg 2001; 72:1576-82
320 SILBER S, SERRUYS PW, LEON MB, et al. Clinical outcome of patients with and without diabetes mellitus and percutaneous coronary intervention with the resolute zotarolimus-eluting stent: 2-year results from the propectively pooled analysis of international global RESOLUTE program. JACC Cardiovasc Interv 2013; 6:357-68
321 SONNTAG H, STEPHAN H, LANGE H, et al. Sufentanil does not block sympathetic response to surgical stimuli in patients having coronary artery revascularization surgery. Anesth Analg 1989; 66:584
322 SPAULDING C, DAEMEN J, BOERSMA E, et al. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007 ; 356 :989-97
323 SPAULDING C, TEIGERT E, COMMEAU P, et al. Four-year follow-up of TYPHOON (Trial to Assess the Use of the Cypher Sirolimus- eluting Coronary Stent in Acute Myocardial Infarction Treated with Balloon angioplasty. JACC Cardiovasc Interv 2011; 4:14-23
324 STEG G, JAMES SK, ATAR D, et al. ESC Guidelines for the management of acute myocardial infarction in pratients presenting with ST-segment elevation. Eur Heart J 2012; 33:2569-619
325 STEIN PD, SCHÜNEMANN HJ, DALEN JE, GUTTERMAN d. Antithrombotic therapy in patients with saphenous vein and internal mammary bypass grafts. The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004; 126:600S-608S
326 STENSETH R, BJELLA L, BERG EM. Effect of thoracic epidural analgesia on coronary hemodynamics and myocardial metabolim in coronary artery bypass surgery. J Cardiothor Vasc Anesth 1995; 9:503-9
327 STETTLER C, WANDEL S, ALLEMAN S, et al. Outcomes associated with drug-eluting and bare-metal stents: A collaborative netwoek meta-analysis. Lancet 2007; 370:937-48
328 STONE GW, MAEHARA A, LANSKY AJ, et al. A prospective netural-history study of coronary atherosclerosis. N Engl J Med 2011; 364:226-35
329 STONE GW, MOSES JW, ELLIS SG, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007; 356:998-1008
330 STONE GW, RIZVI A, NEWMAN W, et al. Everolimus-eluting versus placlitaxel-eluting stents in coronary artery disease. N Engl J Med 2010; 362:1663-74
331 SVORKDAL N. Treatment of inoperable coronary disease and refractory angina: spinal stimulators, epidurals, gene therapy, transmyocardial laser, and counterpulsation. Semin Cardiothorac Vasc Anesth 2004; 8:43-58
332 SYMONS JA, MYLES PS. Myocardial protection with volatile anaesthetic agents during coronary artery bypass surgery: a meta-analysis. Br J Anaesth 2006; 97:127-36
333 TAMHANE U, MEIER P, CHETCUTI S, et al. Efficacy of cilostazol in reducing restenosis in patients undergoing contemporary stent based PCI: a meta-analysis of randomised controlled trials. EuroIntervention 2009; 5:384-93
334 TANAKA K, LUDWIG NM, KERSTEN JR, PAGEL PS, WARLTIER DC. Mechanisms of cardioprotection by volatile anesthetics. Anesthesiology 2004; 100:707-21
335 TANIGUCHI M, KASABA T, TAKASAKI M. Epidural anesthesia enhances sympathetic nerve activity in the unanesthetized segments in cats. Anesth Analg 1997; 84:391-7
336 TARDIFF BE, CALIFF RM, MORRIS D, et al. Coronary revascularization surgery after myocardial infarction: Impact of bypass surgery on survival after thrombolysis. J Am Coll Cardiol 1997; 29:240-9
337 TATOULIS J, BUXTON BF, FULLER JA. Patencies of 2’127 arterial to coronary conduits after 15 years. Ann Thorac surg 2004; 77:93-101
338 THIELMANN M, KOTTENBERG E, KLEINBONGARD P, et al. Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial. Lancet 2013; 382:597-604
339 THUNY F, LAIREZ O, ROUBILLE F, et al. Post-conditioning reduces infarct size and edema in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2012; 59:2175-81
340 THYGESEN K, ALPERT JS, WHITE HD. Universal definition of myocardial infarction. J Am Coll Cardiol 2007; 50:2173-95
341 TOKUDA Y, SONG MH, UEDA Y, et al. Predicting early coronary artery bypass graft failure by intraoperative transit time flow measurement. Ann Thorac Surg 2007; 84:1928-33
342 TOMIYASU S, HARA T, HASUO H, et al. Comparative analysis of systemic and coronary hemodynamics during sevoflurane anesthesia. J Cardiovasc Pharmacol 1999; 33:741
343 TONINO PAL, DE BRUYNE B, PIJLS NHJ, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009; 360:213-24
344 TRITAPEPE L, LANDONI G, GUARRACINO F, et al. Cardiac protection by volatile anaesthetics: a multicentre randomized controlled study in patients undergoing coronary artery bypass surgery grafting with cardiopulmonary bypass. Eur J Anaesthesiol 2007; 24:323-31
345 TUMAN KJ, McCARTHY RJ, MARCH RJ, et al. Effects of epidural anesthesia and analgesia on coagulation and outcome after major vascular surgery. Anesth Analg 1991; 73:696-704
346 UMT/Unité de Médecine Transfusionnelle, CHUV. Rapport annuel 2009. Lausanne, 2010
347 URWIN SC, PARKER MJ, GRIFFITHS R. General versus regional anaesthesia for hip fracture surgery: a meta-analysis of randomized trials. Br J Anaesth 2000; 84:450-5
348 VALGIMIGLI M, CAMPO G, MONTI M, et al (PRODIGY Investigators). Short- versus long-term duration of dual antiplatelet therapy after coronary stenting: a randomized, multi-center trial. Circulation 2012; 125:2015-26
349 VAN BELLE E, RIOUFOL G, POUILLOT C, et al. Revascularization strategy – Reclassification with fractional flow reserve (FFR) at time of diagnostic angiography: insights from a large French multicenter fractional flow reserve registry. Circulation 2014; 129:173-85
350 VANDAELE M, SUTHERLAND G, MITCHELL M, et al. Do changes in pulmonary capillary wedge pressure adequately reflect myocardial ischemia during anesthesia?. Circulation 1990; 81:865-71
351 VAN KLEI WA, BRYSON GL, YANG H, FORSTER AJ. Effect of -blocker prescription on the incidence of postoperative myocardial infarction after hip and knee arthroplasty. Anesthesiology 2009; 111:717-24
351a VAN WAES JA, NATHOE HM, DE GRAAFF JC, et al. Myocardial injury after noncardiac surgery and its association with short-term mortality. Circulation 2013; 127:2264-71
352 VERMEYEN KM, DE HERT SG, ERPELS FA, et al. Myocardial metabolism during anaesthesia with propofol-low dose fentanyl for coronary artery bypass surgery. Br J Anaesth 1991; 66:504-8
353 VOCI P, BILLOTTA F, CARETTA Q, et al. Low dose dobutamine echocardiography predicts the early response of dysfunction myocardial segments to coronary artery bypass grafting. Am Heart J 1995; 129:521-6
354 WAGNER GS, MACFARLANE P, WELLENS H, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogramm. Part VI: acute ischemia/infarction. J Am Coll Cardiol 2009; 53:1003-11
355 Wahl gw, feins rh, aqlfieres g, et al. Reinfusion of shed blood after coronary operation causes elevation of cardiac enzyme levels. Ann Thorac Surg 1992; 53:625-31
356 Wang J, Filipovic M, Rudzitis A, et al. Transesophageal echocardiography for monitoring segmental wall motion during off-pump coronary artery bypass surgery. Anesth Analg 2004; 99:965-73
357 WEINTRAUB WS, GRAU-SEPULVEDA MV, WEISS JM, et al. Comparative effectiveness of revascularization strategies. N Engl J Med 2012; 366:1467-76
358 WEINTRAUB WS, SPERTUS JA, KOLM P, et al. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med 2008; 359:677-87
359 WIJEYSUNDERA DN, BEATTIE WS, AUSTIN PC, et al. Epidural anaesthesia and survival after intermediate-to-high risk non-cardiac surgery: A population-based cohort study. Lancet 2008; 372:562-9
360 WIJNS W, KOHL P, DANCHIN N, et al. Guidelines on myocardial revascularization. The Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2010; 31:2501-55
361 WILLIAMS JP. Effects of thoracic epidural anesthesia on the coagulation system. Bail Clin Anesthesiol 1999; 13:31-56
362 WIN HK, CALDERA AF, MARESH K, et al. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA 2007; 297:2001-9
363 WINDECKER S, MEIER B. Late coronary stent thrombosis. Circulation 2007; 116:1952-65
364 Wiviott SD, Braunwald E, ANGIOLILLO DJ, et al. Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel – thrombolysis in myocardial infarction 38. Circulation 2008; 118: 1626-36
365 WRIGHT RS, ANDERSON JL, ADAMS CD, et al. 2011 ACCF/AHA focused update of the Guidelines for the management of patients with unstable angine/non-ST-elevation myocardial infarction (updating the 2007 Guideline). Circulation 2011; 123:2022-60
366 XUE F, YANG X, ZHANG B, et al. Postconditioning the human heart in percutaneous coronary intervention. Clin Cardiol 2010; 33:439-44
367 Yancy CW, Fowler MB, Colucci WS, et al. Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure. N Engl J Med 2001; 344:1358-1365
368 YELLON DM, HAUSENLOY DJ. Myocardial reperfusion injury. N Engl J Med 2007; 357:1121-35
369 YU CH, BEATTIE WC. The effects of volatile anaesthetics on cardiac ischemic complications and mortality in CABG: A meta-analysis. Can J Anaesth 2006; 53:906-18
370 YUSUF S, ZUKER D, PEDUZZI P, et al. Effect of coronary artery bypass graft surgery on survival: Overview of ten years results from randomized trials by the Coronary Artery Bypass Graft Surgery Trialist Collaboration. Lancet 1994; 344:563-70
371 ZACHARIAS A, SCHWANN TA, RIORDAN CJ, et al. Late results of conventional versus all-arterial revascularization based on internal thoracic and radial artery grafting. Ann Thorac Surg 2009; 87:19-26.e2
372 ZANGRILLO A, TESTA V, ALDROVANDI V, et al. Volatile agents for cardiac protection in noncardiac surgery: A rendomized controlled study. J Cardiothorac Vasc Anesth 2011; 25:902-7
373 ZAUGG M, LUCHINETTI E, SPAHN DR, et al. Differential effects of anesthetics on mnitochondrial KATP channel activity and cardiomyocyte protection. Anesthesiology 2002; 97:15-23
374 ZAUGG M, SCHAUB MC, FOËX P. Myocardial injury and its prevention in the perioperative setting. Br J Anaesth 2004; 93:21-33
375 ZSIGMOND EK, KELSCH RC, KOTHARI SP. Rise in plasma free norepinephrine during anesthetic induction with ketamine. Behav Neuropsychiatry 1974; 6:81